Syndax Pharmaceuticals (SNDX) Current Leases (2019 - 2025)
Historic Current Leases for Syndax Pharmaceuticals (SNDX) over the last 7 years, with Q3 2025 value amounting to $329000.0.
- Syndax Pharmaceuticals' Current Leases fell 6092.64% to $329000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $329000.0, marking a year-over-year decrease of 6092.64%. This contributed to the annual value of $471000.0 for FY2024, which is 5449.28% down from last year.
- Latest data reveals that Syndax Pharmaceuticals reported Current Leases of $329000.0 as of Q3 2025, which was down 6092.64% from $344000.0 recorded in Q2 2025.
- In the past 5 years, Syndax Pharmaceuticals' Current Leases registered a high of $1.0 million during Q1 2024, and its lowest value of $299000.0 during Q2 2022.
- For the 5-year period, Syndax Pharmaceuticals' Current Leases averaged around $577105.3, with its median value being $454000.0 (2023).
- As far as peak fluctuations go, Syndax Pharmaceuticals' Current Leases skyrocketed by 22006.69% in 2023, and later tumbled by 6493.37% in 2025.
- Over the past 5 years, Syndax Pharmaceuticals' Current Leases (Quarter) stood at $361000.0 in 2021, then rose by 20.22% to $434000.0 in 2022, then surged by 138.48% to $1.0 million in 2023, then plummeted by 54.49% to $471000.0 in 2024, then tumbled by 30.15% to $329000.0 in 2025.
- Its Current Leases was $329000.0 in Q3 2025, compared to $344000.0 in Q2 2025 and $377000.0 in Q1 2025.